MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Utility of the Montreal cognitive assessment for screening of mild cognitive impairment and dementia associated with Parkinson’s disease in a Colombian hospital

    S.C. Cerquera Cleves, S.J. Romero Vanegas, F. Cruz Sanabria, C. Ruiz de Sánchez, F.F. Pretelt Burgos (Bogotá, Colombia)

    Objective: To determine the discriminant ability of the Montreal Cognitive Assessment (MOCA) for detection of dementia or any cognitive impairment in patients with Parkinson's disease…
  • 2016 International Congress

    Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists

    M.E. Mohammad, J.A. Vizcarra, K. O'Donnell, S. Patel, X. Garcia, X.X. Yu, K. Vlastaris, K. Sutton, H.H. Fernandez (Cleveland, OH, USA)

    Objective: To evaluate the clinician response to Parkinson patients who developed behavioral side effects from dopamine agonists. Background: Side effects from dopamine agonists can be…
  • 2016 International Congress

    Cytokines in CSF and plasma as potential biomarkers for PD cognitive impairment

    M. Delgado-Alvarado, B. Gago, A. Gorostidi, H. Jiménez-Urbieta, J. Ruiz-Martínez, A. Bergaretxe-Yarza, J.F. Martí-Massó, P. Martínez-Lage, A. Izagirre, A. Oregi, L. Sepúlveda, M.C. Rodríguez-Oroz (San Sebastián, Spain)

    Objective: To assess CSF and plasmatic levels of cytokines as potential biomarkers of PD and PD mild cognitive impairment (PD-MCI). Background: Neuroinflammation may play a…
  • 2016 International Congress

    Executive function and verbal fluency in patients with Parkinson’s disease

    A.F. Barbosa, M.C. Voos, C.O. Souza, J. Chen, H.F. Chien, D.V. Francato, E.R. Barbosa, L.L. Mansur (São Paulo, Brazil)

    Objective: To determine whether the phonemic verbal fluency test is a purely cognitive measure or involves cognitive-motor interaction, if related to TMT. Background: Two of…
  • 2016 International Congress

    Association between cognitive status and mobility performance in dual task condition in patients with Parkinson’s disease

    S.M.A.A. Pompeu, T.B. Freitas, K.G. Silva, C. Torriani-Pasin, F. Doná, J.E. Pompeu (São Paulo, Brazil)

    Objective: To analyzed the association of cognitive status (CS) and mobility performance in dual task conditions in Parkinson's disease patients (PDP) and to assess the…
  • 2016 International Congress

    Functional connectivity during resting state in Parkinson’s disease patients with and without mild cognitive impairment

    O. Monchi, A. Nagano-Saito, A. Hanganu, S. Jobert, B. Mejia-Constain, C. Degroot, A.L. Lafontaine, H. Chertkow, A. Tam, P. Orban, P. Bellec, O. Monchi (Calgary, AB, Canada)

    Objective: Determine whole brain functional connectivity changes in Parkinson's disease (PD) with mild Cognitive Impairment (MCI), using bootstrap analysis of stable cluster (BASC) method to…
  • 2016 International Congress

    Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia

    N.G. Sokhibnazarov, F.K. Shermukhamedova (Tashkent, Uzbekistan)

    Objective: Aim of this study was to identify the degree of cognitive dysfunction in patients with subcortical Parkinsonian dementia, during the neuroprotective therapy. Background: Parkinson's…
  • 2016 International Congress

    The role of depression in suicidal ideation in a sample of patients with Parkinson’s disease

    M.M. Dumitru (Iasi, Romania)

    Objective: The objective of this study was to assess the frequency of suicidal ideation and suicide attempts in a sample of consecutive patients with Parkinson's…
  • 2016 International Congress

    The cerebral structural and functional signatures of impulse control disorder in Parkinson’s disease

    F. Imperiale, F. Agosta, E. Canu, V. Špica, M. Jecmenica, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)

    Objective: To assess cortical thickness (CT) measures, white matter (WM) microstructural damage, and resting state (RS) functional connectivity alterations in patients with Parkinson's disease and…
  • 2016 International Congress

    Dropped head syndrome in parkinsonism: Two treatable etiologies not to miss

    P. Termsarasab, S.J. Frucht (New York, NY, USA)

    Objective: To report the etiology of treatable head drop in Parkinson's disease (PD): one patient from rotigotine patch and the other two from neck extensor…
  • « Previous Page
  • 1
  • …
  • 124
  • 125
  • 126
  • 127
  • 128
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley